Kenvue Health (KVUE) - Gross Profitability

Corporate emblem and logo of Kenvue Inc (KVUE)

The gross margin reflects cost efficiency, with the metric currently standing at 58.60. Kenvue Inc. (KVUE) leverages global distribution and standardized technical processes of its well-known brands to drive scalability. The defensive nature of the business ensures stable demand for pharmacy products regardless of crises. Human capital is bolstered by experienced chemists and a strong team of brand managers.

Kenvue Corp (KVUE) Gross Margin: for the period 02/21/2024 - 11/14/2026

Financial and market metric breakdowns for kenvue.com (KVUE)

- stock quotes and analyst forecast:
Basic company analysis:Kenvue
Manufactured products of Kenvue Inc.

Job stability and the focus of Kenvue Inc. (KVUE) on consumer health are directly reflected in the changes to its gross margin. This indicator captures the portion of revenue remaining after deducting direct production costs. The calculation is performed by dividing the difference between total income and the cost of goods sold by the sales volume. A high level of this ratio confirms efficient resource management and the fundamental resilience of the business model.

Direct competitors

Gross Profit Margin Haleon PLC (HLN)|Gross Profitability veronapharma.com|Gross Return on Sales MENS (Jyong Biotech Corp)|Gross Profitability Ligand (LGND)|Gross Margin amneal.com (AMRX)|Gross Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Gross Profit Margin|Liquidia Inc. - Gross Margin|Gross Sales Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Gross Profitability|Gross Return on Sales MNKD|Gross Profitability Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Return on Sales by Gross Profit|Gross Margin SPRY|TBPH - Gross Profit Margin|Aquestive Pharma - Return on Gross Profit|Gross Margin scpharmaceuticals.com SCPH|Tectonic - Gross Margin|TNXP - Gross Margin|SXTC: Gross Margin|Eupraxia Pharma - Gross Profit Rate|BHST (bioharvest.com) - Gross Margin|Gross Return on Sales EXOZ (invizyne.com)|Gross Margin ORMP|Return on Sales by Gross Profit Entera Bio|Gross Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Gross Profitability|Cumberland Corp - Gross Margin|QNTM - Gross Margin|FibroGen, Inc. (FGEN) - Gross Profitability|TELO: Gross Profit Ratio|RANI (Rani Therapeutics Inc) - Gross Margin|Gross Profit Margin synergychc.com SNYR|Gross Profitability Rallybio Corp. (RLYB)|LEXX - Gross Profit Margin|Gross Margin PULM (pulmatrix.com)|Gross Profit Ratio PTHL (Pheton)|APM - Gross Profitability|Return on Sales by Gross Profit Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Gross Profitability|TNF Pharma (TNFA) - Gross Margin|YCBD (cbdmd.com) - Gross Margin|Return on Gross Profit PainReform (PRFX)|Gross Profitability Altamira Therapeutics (CYTO)|Return on Sales by Gross Profit Lipella Pharma|Optinose - Return on Gross Profit|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin